Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single‐centre audit of cellulitis outcomes
Internal Medicine Journal · 2024-02 · 54 (2) · 320-327
DOI: 10.1111/imj.16173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, online erschienen am 18.07.2023. Verfasst von Thomas R Bowhay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Dunedin Public Hospital, Te Whatu Ora (Health New Zealand) Southern, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Cellulitis, Anti-Infective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Francis G. Cotter Scholarship for Research in Medicine.
Abstract (Originalsprache)
Background
Cellulitis is a common acute skin and soft tissue infection that causes substantial morbidity and healthcare costs.
Aims
To audit the impact on cellulitis management, regimen tolerability and outcomes of switching from outpatient parenteral antimicrobial therapy (OPAT) using intravenous (i.v.) cefazolin once daily plus probenecid to oral beta‐lactam therapy (OBLT) using oral flucloxacillin plus probenecid.
Methods
We undertook a retrospective audit on cellulitis management, regimen tolerability and outcomes at the Dunedin Public Hospital Emergency Department (ED) before and after a change of the local outpatient cellulitis treatment pathway from OPAT using i.v. cefazolin once daily plus probenecid to OBLT using oral flucloxacillin plus probenecid.
Results
OPAT was used in 97/123 (78.9%) patients with cellulitis before compared to 1/70 (1.4%) after the pathway change (odds ratio (OR), 0.04, P < 0.01). OBLT was used in 26/123 (21.1%) patients with cellulitis before and 69/70 (98.6%) after (OR, 218.8, P < 0.01). Antimicrobial change due to intolerance occurred in 4/123 (3.2%) patients with cellulitis before and 4/70 (5.7%) after (OR, 1.8, P , not significant (NS)) the pathway change. Inpatient admission within 28 days occurred in 15/123 (12.2%) cellulitis patients before and 9/70 (12.9%) after (OR, 1.1, P , NS) the pathway change.
Conclusions
Implementation of a change in outpatient cellulitis treatment pathway resulted in a significant change in prescribing practice. Our findings suggest that OBLT was both tolerable and had similar outcomes to OPAT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dunedin Public Hospital, Te Whatu Ora (Health New Zealand) Southern, Dunedin, New Zealand.
- Centre for International Health, University of Otago, Dunedin, New Zealand.
- Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
ORCID-Profile: Thomas R Bowhay
Förderung
- Francis G. Cotter Scholarship for Research in Medicine
Zitieren
APA
Bowhay, T. R., Tsang, T., Wei, J. C. Z., Edwik, W., Fridman, A., Hubber, J., Jo, J. Y., Mckay, N., O'Brien, C., Osmond-Wallam, J., Smythe, J., Crump, J. A., & Arnold, B. (2024). Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single‐centre audit of cellulitis outcomes. Internal Medicine Journal, 54(2), 320-327. https://doi.org/10.1111/imj.16173
Vancouver
Bowhay TR, Tsang T, Wei JCZ, Edwik W, Fridman A, Hubber J, et al. Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single‐centre audit of cellulitis outcomes. Internal Medicine Journal. 2024;54(2):320-327. doi:10.1111/imj.16173
BibTeX
@article{Bowhay2024,
author = {Bowhay, Thomas R and Tsang, Tiffany and Wei, Jeremy C Z and Edwik, Wafa and Fridman, Avi and Hubber, Julia and Jo, Jae Y and Mckay, Nicole and O'Brien, Catherine and Osmond-Wallam, Joe and Smythe, James and Crump, John A and Arnold, Brendan},
title = {Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single‐centre audit of cellulitis outcomes},
journal = {Internal Medicine Journal},
year = {2024},
volume = {54},
number = {2},
pages = {320--327},
doi = {10.1111/imj.16173}
}
EUVIMED